How is Australia responding to the pharmaceutical opioid problem?

February 2019
Dr Gabrielle Campbell NHMRC Australian Public Health Early Career Fellow at NDARC, UNSW.
Read more
October 2018

Clinical practice guidelines: Questions of relevance, reliability and utility explored

Professor Ann Roche, Director, NCETA
August 2018

Can we improve processes for engaging communities and services in research?

Professor Anthony Shakeshaft, National Drug and Alcohol Research Centre, UNSW Sydney
June 2018

Renewed interest in psychedelics as potentially useful therapeutic agents

NDRI Adjunct Research Fellow Dr Stephen Bright shares his views about psychedelic research programs that have been initiated by several prestigious in
May 2018

Wastewater analysis - what does it mean for AOD policy and practice?

Ann Roche, Director & Allan Trifonoff, Deputy Director (Programs), NCETA
March 2018

To reduce child injury deaths in Australia we need to look at the link to adult alcohol consumption

Dr Anne-Marie Laslett, Senior Research Fellow, NDRI
December 2017

Health economics is not just about measuring costs

Dr Marian Shanahan, NDARC
October 2017

Drug testing: How it works and what it can, and cannot, achieve

Associate Professor Ken Pidd, Deputy Director (Research), NCETA
August 2017

The New Zealand 2017 Parliamentary Drug Policy Symposium

Professor Alison Ritter Director, Drug Policy Modelling Program
June 2017

More research needed to address complex questions raised by take-home naloxone

Dr Adrian Farrugia and Professor Suzanne Fraser, National Drug Research Institute, Melbourne office
May 2017

Finding an evidence based intervention for methamphetamine-using women

Zahra Alam Mehrjerdi, NDARC

Pages